Integrating genomic features for prognosis in Chinese patients with diffuse large B-cell lymphoma following R-CHOP therapy
Annals of Hematology · 03.06.2026 · 105 (8)
DOI: 10.1007/s00277-026-07085-y ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Hematology, online erschienen am 03.06.2026. Verfasst von Shi Han und 17 weiteren Autor:innen. Beteiligte Einrichtung: Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, No.79 Qingchun Roa…. Hauptthemen laut MEDLINE: Antineoplastic Combined Chemotherapy Protocols, Lymphoma, Large B-Cell, Diffuse, Mutation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Sanming Project of Medicine in Shenzhen, the Zhejiang Provincial Department of Science and Technology "Jianbing Lingyan+X" Research and Development Project Plan, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, No.79 Qingchun Road, Hangzhou, 310000, China.
- Institute of Hematology, Zhejiang University, Hangzhou, 310000, China.
- Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, 310000, China.
- Department of Hematology and Oncology, Shenzhen University General Hospital, International Cancer Center of Shenzhen University, Shenzhen University Medical School, Shenzhen University, Shenzhen, 518000, China.
- Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, No.79 Qingchun Road, Hangzhou, 310000, China. 1313016@zju.edu.cn.
- Institute of Hematology, Zhejiang University, Hangzhou, 310000, China. 1313016@zju.edu.cn.
Förderung
- Sanming Project of Medicine in Shenzhen
- the Zhejiang Provincial Department of Science and Technology "Jianbing Lingyan+X" Research and Development Project Plan
- National Natural Science Foundation of China
- the National Science Fund for Distinguished Young Scholars
- the Zhejiang Provincial Department of Science and Technology “Jianbing Lingyan+X” Research and Development Project Plan
Zitieren
APA
Han, S., Zhou, L., Zheng, H., Zhao, Y., Cai, Z., He, J., Ye, X., Wu, W., Sun, J., Zheng, W., Wei, G., Yu, L., Wang, L., Gao, K., Yue, J., Zhang, M., Hu, Y., & Huang, H. (2026). Integrating genomic features for prognosis in Chinese patients with diffuse large B-cell lymphoma following R-CHOP therapy. Annals of Hematology, 105(8). https://doi.org/10.1007/s00277-026-07085-y
Vancouver
Han S, Zhou L, Zheng H, Zhao Y, Cai Z, He J, et al. Integrating genomic features for prognosis in Chinese patients with diffuse large B-cell lymphoma following R-CHOP therapy. Annals of Hematology. 2026;105(8). doi:10.1007/s00277-026-07085-y
BibTeX
@article{Han2026,
author = {Han, Shi and Zhou, Linghui and Zheng, Haiqiong and Zhao, Yi and Cai, Zhen and He, Jingsong and Ye, Xiujin and Wu, Wenjun and Sun, Jie and Zheng, Weiyan and Wei, Guoqing and Yu, Li and Wang, Lixin and Gao, Ke and Yue, Juan and Zhang, Mingming and Hu, Yongxian and Huang, He},
title = {Integrating genomic features for prognosis in Chinese patients with diffuse large B-cell lymphoma following R-CHOP therapy},
journal = {Annals of Hematology},
year = {2026},
volume = {105},
number = {8},
doi = {10.1007/s00277-026-07085-y}
}
EUVIMED